Skip to main content

Advertisement

Springer Nature Link
Log in

Cystic fibrosis

  • Review
  • Published:
Lung Aims and scope Submit manuscript

Abstract

While the care of cystic fibrosis (CF) patients has been mainly the province of pediatricians, great improvements in the therapy and life span of CF patients often results in their transition to care by adult physicians. In this review of CF, we begin with an overview of the epidemiology and genetics of the disease, with a discussion of the recently found ion abnormalities that lead to the clinical manifestations. This is followed by a discussion of the pathophysiology. Methods of diagnosis, ranging from the gold standard, the sweat test, to recent advances based on a greater understanding of the genetics of the disease are reviewed. This is followed by a discussion of therapy primarily geared to the treatment of the respiratory complications, as they are the most common lethal factors of the disease. We point out controversies where they exist. Newer forms of therapy such as lung transplantation are discussed, and we finish with a discussion about future therapeutic modalities, some of which are being approved as the paper is in print.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Abernathy RS (1976) Bulging fontanelle as presenting sign in cystic fibrosis. Am J Dis Child 130:1360–1362

    Google Scholar 

  2. Abman SH, Ogle JW, Harbeck RJ et al (1991) Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr 119: 211

    Google Scholar 

  3. Adeniyi-Jones SK, Suskind R, Bean B et al (1979) Growth, energy metabolism and T3 levels in malnutrition in cystic fibrosis. Cystic Fibrosis Club Abs 20:22

    Google Scholar 

  4. Alton E, Khagani A, Taylor R et al (1991) Effect of heart-lung transplantation on airway potential difference in patients with and without cystic fibrosis. Eur Respir J 4:5–9

    Google Scholar 

  5. Anderson DH (1938) Cystic fibrosis of the pancreas and its relation to celiac disease: Clinical and pathological study. AJDC 56:344

    Google Scholar 

  6. Anderson DH (1949) Therapy and prognosis of fibrocystic disease of the pancreas. Pediatrics 3:406

    Google Scholar 

  7. Anderson MP, Gregory RJ, Thompson S et al (1991) Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253:202–205

    Google Scholar 

  8. Antonarakis SE (1989) Diagnosis of genetic disorders at the DNA level. N Engl J Med 320:153–163

    Google Scholar 

  9. Antonowicz I, Shwachman H (1979) Meconium in health and in disease. Adv Pediatr 26:275–310

    Google Scholar 

  10. Baer CE, Li CH, Kartner N et al (1992) Purification and functional reconstruction of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68:809–818

    Google Scholar 

  11. Balistreri WF (1990) Spectrum of liver disease in patients with cystic fibrosis. Pediatr Pulmonol (suppl)5:71–73

    Google Scholar 

  12. Baodian M (1952) Fibrocystic disease of the pancreas. Heinemann, London

    Google Scholar 

  13. Barasch J, Kiss B, Prince A, Saiman L, Gruehert D, Al-Awgati Q (1991) Defective acidification of intracellular organelles in cystic fibrosis. Nature 352:70–73

    Google Scholar 

  14. Bateman JRM, Newman SP, Daunt KM, Sheahan NF, Pavia D, Clarke SW (1981) Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax 36:683–687

    Google Scholar 

  15. Beaudet AL, Buffone GJ (1987) Prenatal diagnosis of cystic fibrosis. J Pediatr 111(4):630–633

    Google Scholar 

  16. Beaudet AL, Feldman GL, Fernbach SD et al (1989) Linkage disequilibrium, cystic fibrosis, and genetic counseling. Am J Hum Genet 44:319–326

    Google Scholar 

  17. Beaudry PH, Marks MI, McDougall D et al (1980) Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr 97:144

    Google Scholar 

  18. Blomquist M, Freyschuss U, Wiman LG, Standvik B (1986) Physical activity and self treatment in cystic fibrosis. Arch Dis Child 61:362–367.

    Google Scholar 

  19. Boucher RC (1992) Drug therapy in the 1990's. What can we expect for cystic fibrosis? Drugs 43:431–437

    Google Scholar 

  20. Brock DJH, Shrimpton AE, Jones C, McIntosh I (1991) Cystic Fibrosis: The new genetics. J R Soc Med 84(suppl 18):2–6

    Google Scholar 

  21. Brown RE, Madge GE (1971) Cystic fibrosis and nesidioblastosis. Arch Pathol 92:53–57

    Google Scholar 

  22. Brugman SM, Taussig LM (1984) The reproductive system. In: Taussig LM (ed), Cystic fibrosis. Thieme-Stratton, New York, pp 323–337

    Google Scholar 

  23. Bye MR (1992) Causes of decreased height and weight in cystic fibrosis patients. Pediatr Rev 13:73

    Google Scholar 

  24. Cacalano G, Kays M, Saiman L, Prince A (1992) Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J Clin Invest 89:1866–1874

    Google Scholar 

  25. Caine N, Sharples L, Smyth R et al (1991) Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc 23:1203–1204

    Google Scholar 

  26. Caskey C, Kaback M, Beaudet A et al (1990) The American Society of Human Genetics Statement on Cystic Fibrosis screening. Am J Hum Genet 46:395

    Google Scholar 

  27. Cerny FJ (1989) Relative effects of bronchial drainage and exercise for in hospital care of patients with cystic fibrosis. Phys Ther 69:633–639

    Google Scholar 

  28. Chase HP, Cotton EK, Elliott RB (1979) Intravenous linoleic acid supplementation in children with cystic fibrosis. Pediatrics 64:207–213

    Google Scholar 

  29. Chase HP, Long MA, Lavin MH (1979) Cystic fibrosis and malnutrition. J Pediatr 95:337–347

    Google Scholar 

  30. Coffey MJ, Fitzgerald MX, McNicholas WT (1991) Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest 100:659–662

    Google Scholar 

  31. Collins FS (1992) Cystic fibrosis: molecular biology and therapeutic implications. Science 256:774–779

    Google Scholar 

  32. Cox KL (1990) The role of liver transplantation in cystic fibrosis patients. Pediatr Pulmonol (suppl 5):78–80

  33. Cox KL, Ward RE, Furgiuele TL, Cannon RA, Sanders KD, Kurland G (1987) Orthotopic liver transplantation in patients with cystic fibrosis. Pediatrics 80:571–574

    Google Scholar 

  34. Cropp GJA, Aneja S, Bye MR (1982) Oxygen cost of breathing and CO2 responses in cystic fibrosis. Chest 82:242A

    Google Scholar 

  35. Cuthing GR, Aatenarakis SE, Buetow KH, Kash LM, Rosenstein BJ, Kazazian HH (1989) Analysis of DNA Polymerism haplotypes linked to the cystic fibrosis locus in North American black and caucasian families supports the existence of multiple mutations of the cystic fibrosis, gene. Am J Hum Genet 44:307–318

    Google Scholar 

  36. DeBoeck C, Zinman R (1984) Cough versus chest physiotherapy. Am Rev Respir Dis 129: 182–184

    Google Scholar 

  37. Desmond KJ, Schwenk F, Thomas E, Beaudry PH, Coates AL (1983) Immediate and longterm effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr 103:538–542

    Google Scholar 

  38. diSant'Agnese PS, Blanc WA (1956) A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas. Recognition through signs of portal hypertension. Pediatrics 18:387

    Google Scholar 

  39. diSant'Agnese PA, Darling RC, Perera GA et al (1953) Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas: Clinical significance and relationship to the disease. Pediatrics 12:549–563

    Google Scholar 

  40. diSant'Agnese PA, Hubbard VS (1984) The hepatobiliary system. In: Taussig LM (ed) Cystic fibrosis. Thieme-Stratton, New York, pp 296–322

    Google Scholar 

  41. Dorin JR, Dickinson P, Alton E et al (1992) Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359:211–215

    Google Scholar 

  42. Esterly JR, Oppenheimer EH, Landing BH (1976) Pathology of cystic fibrosis. In: Mangos JA, Talamo RC (eds) Cystic fibrosis. Stratton Intercontinental, New York, p 115

    Google Scholar 

  43. Feigelson J, Pecau Y, Savuegrain J (1970) Liver function studies and biliary tract investigations in mucoviscidosis. Acta Pediatr Scand 59:539–544

    Google Scholar 

  44. Fick RB Jr (1989) Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis. Chest 96:158

    Google Scholar 

  45. Fiel SB (1993) Clinical management of pulmonary disease in cystic fibrosis. Lancet 341:1070–1074

    Google Scholar 

  46. FitzSimmons SC (1993) The changing epidemiology of cystic fibrosis. J Pediatr 122:1–9

    Google Scholar 

  47. Forstner G, Gall G, Corey M et al (1980) Digestion and absorption of nutrients in cystic fibrosis. In: Sturgess JM (ed) Perspectives in cystic fibrosis. Proceedings of the 8th International Cystic Fibrosis Congress. Toronto, Imperial Press Ltd, p 137

    Google Scholar 

  48. Francis PWJ, Muller NL, Gurwitz D, Milligan DWA, Levison H, Bryan AC (1980) Hemoglobin desaturation. Its occurrence during sleep in patients with cystic fibrosis. AJDC 134: 734–740

    Google Scholar 

  49. Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G (1982) Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 100:857–862

    Google Scholar 

  50. 50.Geddes DM (1988) Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia. Chest 94(2):140S

    Google Scholar 

  51. Gibson LE, Cooke RE (1959) A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23:545–549

    Google Scholar 

  52. Godfrey S, Bar-Yishay E, Arad I et al (1983) Flow-volume curves in infants with lung disease. Pediatrics 72:517–522

    Google Scholar 

  53. Gold R, Carpenter S, Heurter H et al (1987) Randomized trial of certazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr 111:907

    Google Scholar 

  54. Goldmann DA, Klinger JD (1986) Pseudomonas cepacia: Biology, mechanisms of virulence, epidemiology. J Pediatr 108(2):806

    Google Scholar 

  55. Green J, Bunyan J (1969) Vitamin E and the biological antioxidant theory. Nutr Abstr Rev 39:321

    Google Scholar 

  56. Haluszka J, Scislicki A (1975) Bronchial lability in children suffering from some disease of the bronchi. Respiration 32:217–226

    Google Scholar 

  57. Handwerger S, Roth J, Gorden P et al (1969) Glucose intolerance in cystic fibrosis. N Engl J Med 281:451–461

    Google Scholar 

  58. Hodson ME (1988) Antibiotic treatment. Aerosol therapy. Chest 94(2):1565

    Google Scholar 

  59. Hodson ME, Penketh ARL, Batten JC (1981) Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet 2:1137

    Google Scholar 

  60. Holsclaw DS, Racmans C, Shwachman H (1971) Intussusception in patients with cystic fibrosis. Pediatrics 58:51–58

    Google Scholar 

  61. Holzer FJ, Olinsky A, Phelan PD (1981) Variability of airways hyper-reactivity and allergy in cystic fibrosis. Arch Dis Child 56:455–459

    Google Scholar 

  62. Hordvik NL, Konig P, Morris D, Kreutz C, Barbero GJ (1985) A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis 131:889–893

    Google Scholar 

  63. Horrevorts AM, Driessen OMJ, Michel MF, Kerrebijn KF (1988) Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics. Chest 94(2):1205

    Google Scholar 

  64. Howard ER, Stamatakis JD, Mowat AP (1984) Management of esophageal varices in children by injection sclerotherapy. J Pediatr Surg 19:2–5

    Google Scholar 

  65. Huang NN, Schidlow DV, Palmer J, Bye MR, Muller D (1988) Cystic Fibrosis. In: Kinney JM, Jeejeebhoy KN, Hill GL, Owen OE (eds) Nutrition and metabolism in patient care. Saunders, Philadelphia, pp 405–428

    Google Scholar 

  66. Hubbard RC, McElvaney NG, Birrer P et al (1992) A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med 326:812–815

    Google Scholar 

  67. Hubbard VS, Farrell PM, diSant'Agnese PA (1979) 25-Hydroxycholecalciferol levels in patients with cystic fibrosis. J Pediatr 94:84–86

    Google Scholar 

  68. Hyatt AC, Chipps BE, Kumor KM et al (1981) A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr 99:307

    Google Scholar 

  69. Isles A, Maclusky I, Corey M et al (1984) Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 104:206–210

    Google Scholar 

  70. Johnson JP (1988) Genetic counseling using linked DNA probes: Cystic fibrosis as a prototype. J Pediatr 113(6):957–964

    Google Scholar 

  71. Kerem B, Rommens JM, Buchanan JA et al (1989) Identification of the cystic fibrosis gene: Genetic analysis. Science 245:1073–1080

    Google Scholar 

  72. Kerem E, Buchanan J, Durie P et al (1989) DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet 44:827–834

    Google Scholar 

  73. Kerem E, Corey M, Kerem B et al (1990) The relation between genotype and phenotype in cystic fibrosis. Analysis of the most common mutation (ΔF508). N Engl J Med 323:1517–1522

    Google Scholar 

  74. Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326:1187–1191

    Google Scholar 

  75. Knowles MR, Church NL, Waltner WE, Yankaskas JR et al (1990) A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 322:1189–1194

    Google Scholar 

  76. Knowles MR, Clarke LL, Boucher RC (1991) Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325:533–538

    Google Scholar 

  77. Knowles MR, Gatzy J, Boucher R (1981) Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 305:1489–1495

    Google Scholar 

  78. Komp DM, Selden RF (1970) Coagulation abnormalities in cystic fibrosis. Chest 58:501

    Google Scholar 

  79. Kraemer R, Rudeberg A, Hadorn B et al (1970) Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 67:33–37

    Google Scholar 

  80. Lapey A, Kattwinkel J, diSant'Agnese PA (1974) Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis. J Pediatr 84:328–334

    Google Scholar 

  81. Lapin CD (1993) Is exercise a substitute for airway clearance techniques? Pediatr Pulmonol (suppl)9:97–98

    Google Scholar 

  82. Lemma WK, Feldman GL, Kerem B et al (1990) Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med 322(5):291–296

    Google Scholar 

  83. Levison H, Godfrey S (1976) Pulmonary aspects. In: Mangos JA, Talamo RE (eds) Cystic fibrosis. Projections into the future. Stratten Intercontinental, New York, p 3

    Google Scholar 

  84. Lewin LO, Byard PJ, Davis PB (1990) Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 43(2):125

    Google Scholar 

  85. L'Heureux PR, Isenberg JN, Short HL et al (1977) Gallbladder disease in cystic fibrosis. Am J Roentgenol 128:953

    Google Scholar 

  86. Lietman PS (1988) Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta lactam antibiotics. Chest 94(2):1155

    Google Scholar 

  87. Lippe BM, Kaplan SA, Neufeld NA et al (1980) Insulin receptors in cystic fibrosis: Increased receptor number and altered affinity. Pediatrics 65:1018–1020

    Google Scholar 

  88. Lipuma JJ, Dasen SE, Nielson DW et al. (1990) Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094

    Google Scholar 

  89. Lloyd-Still JD (1983) Growth, nutrition and gastrointestinal problems. In: Lloyd-Still JD (ed) Textbook of cystic fibrosis. Wright, Boston. pp 227–261

    Google Scholar 

  90. Lowe CU (1972) Cystic fibrosis of the pancreas. In: Barnett HL, Einhorn AH (eds) Pediatrics. Appleton-Century-Crofts, New York. pp 413–430

    Google Scholar 

  91. Maclusky I, Levison H (1990) Cystic fibrosis. In: Chernick V, Kendig EL, (eds) Kendig's disorders of the respiratory tract in children, 5th ed. Saunders, Philadelphia, pp 692–730

    Google Scholar 

  92. Macone AB, Pier GB, Pennington JE et al (1981) Mucoid Escherichia coli in cystic fibrosis. N Engl J Med 304:1445–1449

    Google Scholar 

  93. Mansell AL, Andersen JC, Muttart CF et al (1984) Short-term pulmonary effects of total parenteral nutrition in children with cystic fibrosis. J Pediatr 104:700–705

    Google Scholar 

  94. Marks MI (1990) Staphylococcal aspects of cystic fibrosis. Infection 18:53

    Google Scholar 

  95. Maxwell M, Redmond A (1979) Comparative trial of manual and mechanical percussion technique with gravity-assisted bronchial drainage in patients with cystic fibrosis. Arch Dis Child 54:542–544

    Google Scholar 

  96. McBride JT, Wohl MEB (1979) Pulmonary function tests. Pediatr Clin North Am 26(3):537–550

    Google Scholar 

  97. McElvaney NG, Nakamura, Hebert CA et al (1992) Modulation of airway inflammation in cystic fibrosis. J Clin Invest 90:1296–1301

    Google Scholar 

  98. McLaughlin FJ, Matthews WJ, Strieder DJ, Khaw KT, Schuster S, Shwachman H (1982) Pneumothorax in cystic fibrosis: Management and outcome. J Pediatr 100:863–869

    Google Scholar 

  99. Mellis CM, Levison H (1978) Bronchial reactivity in cystic fibrosis. Pediatrics 61(3):446–450

    Google Scholar 

  100. Michel BC (1988) Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987. Chest 94(2):1298

    Google Scholar 

  101. 101.Mieles LA, Orenstein DM, Toussaint RM, Selby R, Gordon RD, Starzl TE (1991) Outcome after liver transplantation for cystic fibrosis. Pediatr Pulmonol (suppl 6), pp 130–131

  102. Mitchell I, Corey M, Woenne R, Krastins IRB, Levison H (1978) Bronchial hyperreactivity in cystic fibrosis, and asthma. J Pediatr 95(5):744–748

    Google Scholar 

  103. Moss AJ (1982) The cardiovascular system in cystic fibrosis. Pediatrics 70:728–741

    Google Scholar 

  104. Moss RB, Hsu UP, Lewiston NJ (1981) 125I-clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis. J Pediatr 99:215–222

    Google Scholar 

  105. Murray JF (1979) The ketchup-bottle method. N Engl J Med 300:155–157

    Google Scholar 

  106. Padoan R, Cambisano W, Costantini D et al (1987) Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis. Pediatr Infect Dis J 6:648

    Google Scholar 

  107. Park RTW, Grand RJ (1981) Gastrointestinal manifestations of cystic fibrosis. Gastroenterology 81:1143–1161

    Google Scholar 

  108. Parsons HG, Beaudry P, Dumas A, Pencharz PB (1983) Energy needs and growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2:44–49

    Google Scholar 

  109. Pattishall EN (1990) Longitudinal response of pulmonary function to bronchodilators in cystic fibrosis. Pediatr Pulmonol 9:80–85

    Google Scholar 

  110. Pier GB (1985) Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: Current status of the host-bacterium interaction. J Infect Dis 151:575

    Google Scholar 

  111. Pier GB, Saunders JM, Ames P et al (1987) Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older non-colonized patients with CF. N Engl J Med 317:793–798

    Google Scholar 

  112. Pryor JA, Webber BA, Hodson ME, Batten JC (1979) Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of CF. Br Med J 2:417–418

    Google Scholar 

  113. Raffensperger JG (1983) Surgical problems in cystic fibrosis. In: Lloyd-Still JD (ed). Textbook of cystic fibrosis John Wright, Boston. pp 378–379

    Google Scholar 

  114. Ramsey BW, Dorkin HL, Eisenberg JD et al (1993) Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 328:1740–1746

    Google Scholar 

  115. Redmond AOB, Buchanan KD, Trimble ER (1977) Insulin and glucagon response to arginine infusion in cystic fibrosis. Acta Paediatr Scand 66:199–204

    Google Scholar 

  116. Regelmann WE, Elliott GR, Warwick WJ, Clawson CC (1990) Reduction of sputum PA density by antibiotics improve lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 141:914–921

    Google Scholar 

  117. Reisman JJ, Rivington-Law B, Corey M, Marcotte J, Wannamaker E, Harcourt D, Levison H (1988) Role of conventional physiotherapy in cystic fibrosis. J Pediatr 113:632–636

    Google Scholar 

  118. Reiter EO, Brugman SM, Pike JW et al (1985) Vitamin D metabolites in adolescents and young adults with cystic fibrosis: Effects of sun and season. J Pediatr 106:21–26

    Google Scholar 

  119. Riordan JR, Rommens JM, Kerem B et al (1989) Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066–1073

    Google Scholar 

  120. Romeo G, Devoto M, Galietta LJV (1989) Why is the cystic fibrosis gene so frequent? Hum Genet 84:1–5

    Google Scholar 

  121. Rommens JM, Iannuzzi MC, Kerem B et al (1989) Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245:1059–1065

    Google Scholar 

  122. Rosenfeld MA, Yoshimura K, Trapnell BC et al (1992) In vivo transfer of the human CFTR gene to the airway epithelium. Cell 68:143–155

    Google Scholar 

  123. Rossman CM, Waldes R, Sampson D, Newhouse MT (1982) Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis 126:131–135

    Google Scholar 

  124. Rubio TT (1986) Infection in patients with cystic fibrosis. Am J Med 81 (suppl 1A):73

    Google Scholar 

  125. Schoni MH (1989) Autogenic drainage: A modern approach to physiotherapy in cystic fibrosis. J R Soc Med 82(16):32–37

    Google Scholar 

  126. Schuster SR, Shwachman H, Toyama WM et al (1977) The management of portal hypertension in cystic fibrosis. J Pediatr Surg 12:201

    Google Scholar 

  127. Schwarz HP, Kraemer R, Thurnheer U et al (1978) Liver involvement in cystic fibrosis. Helv Pediatr Acta 33:351

    Google Scholar 

  128. Shepherd R, Cooksley WGE, Cooke WDD (1980) Improved growth and clinical, nutritional and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr 97:351–357

    Google Scholar 

  129. Shwachman H, Holsclaw DS (1969) Complications of cystic fibrosis. N Engl J Med 281:500–501

    Google Scholar 

  130. Smith AL (1986) Antibiotic therapy in cystic fibrosis: Evaluation of clinical trials. J Pediatr 108:866

    Google Scholar 

  131. Snouwaert JN, Brigman KK, Latour AM et al (1992) An animal model for cystic fibrosis made by gene targeting. Science 257:1083–1088

    Google Scholar 

  132. Spencer H (1977) Pathology of the lung, 3rd ed. Saunders, Philadelphia, p 48

    Google Scholar 

  133. Steen HJ, Redmond AOB, O'Neill D, Beattie F (1991) Evaluation of the PEP mask in cystic fibrosis. Acta Paediatr Scand 80:51–56

    Google Scholar 

  134. Stern RC, Stevens DP, Boat TF, Doershuk CF, Izant RJ, Matthews LW (1976) Symptomatic hepatic disease in cystic fibrosis: Incidence, course and outcome of portal systemic shunting. Gastroenterology 70:645–649

    Google Scholar 

  135. Strong T, Shut L, Turpin S et al (1991) Cystic fibrosis gene mutation in two sisters with mild disease and normal sweat electrolyte levels. N Engl J Med 325:1630–1634

    Google Scholar 

  136. Sullivan MM, Denning CR (1989) Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 84:642–647

    Google Scholar 

  137. Sutton PP, Pavia D, Bateman JRM, Clarke SW (1982) Chest physiotherapy: A review. Eur J Respir Dis 63:188–201

    Google Scholar 

  138. Szaff M, Hoiby N, Flensborg EW (1983) Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 72:651

    Google Scholar 

  139. Tablan OC, Chorba TL, Schidlow DV et al (1985) Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcome. J Pediatr 107:382

    Google Scholar 

  140. Tepper RS, Hiatt PW, Eigen H, Smith J (1987) Total respiratory system compliance in asymptomatic infants with cystic fibrosis. Am Rev Respir Dis 135:1075–1079

    Google Scholar 

  141. Tepper RS, Skatrud JB, Dempsey JA (1983) Ventilation and oxygenation changes during sleep in cystic fibrosis. Chest 84:388–393

    Google Scholar 

  142. Thomaidis T, Arey J (1963) The intestinal lesions in cystic fibrosis of the pancreas. J Pediatr 63:444–453

    Google Scholar 

  143. Thomassen MJ, Demko CA, Doershuk CF et al (1986) Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis 134:669

    Google Scholar 

  144. Tizzano EF, Buchwald M (1992) Cystic fibrosis: Beyond the gene to therapy. J Pediatr 120:337–349

    Google Scholar 

  145. Trezise AEO, Buchwald M (1991) In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature 353:434–437

    Google Scholar 

  146. Tsui L-C, Buchwald M, Barker D et al (1985) Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230:1054–1057

    Google Scholar 

  147. Underwood BA, Denning CR (1972) Blood and liver concentrations of vitamins A and E in children with cystic fibrosis of the pancreas. Pediatr Res 6:26–31

    Google Scholar 

  148. Vaisman N, Pencharz PB, Corey M, Canny GJ, Hahn E (1987) Energy expenditure of patients with cystic fibrosis. J Pediatr 111:496–500

    Google Scholar 

  149. Van Asperen P, Mellis CM, South RT, Simpson SJ (1981) Bronchial reactivity in cystic fibrosis with normal pulmonary function. AJDC 135:815–819

    Google Scholar 

  150. Walters TR, Koch HF (1972) Hemorrhagic diathesis and cystic fibrosis in infancy. Am J Dis Child 124:641

    Google Scholar 

  151. Webster R, Williams H (1953) Hepatic cirrhosis associated with fibrocystic disease of the pancreas. Arch Dis Child 28:343

    Google Scholar 

  152. Wheeler WB, Williams M, Mathews WJ et al (1984) Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: A five year longitudinal study. J Pediatr 104:695

    Google Scholar 

  153. Wientzen R, Prestidge CB, Kramer RI et al (1980) Acute pulmonary exacerbations in cystic fibrosis. AJDC 134:1134

    Google Scholar 

  154. Williams TJ, Patterson A, McClean PA, Zamel N, Maurer JU (1992) Maximal exercise testing in CF and double lung transplant recipients. Am Rev Respir Dis 145:101–105

    Google Scholar 

  155. Wilroy RS, Crawford SE, Johnson WW (1966) Cystic fibrosis with extensive fat replacement of the liver. J Pediatr 68:67

    Google Scholar 

  156. Wilson DO, Rogers RM, Hoffman RM (1985) Nutrition and chronic lung disease. Am Rev Respir Dis 132:1347–1365

    Google Scholar 

  157. Wood RE (1984) Prognosis. In: Taussing LM (ed) Cystic fibrosis. Thieme-Stratton, New York, pp 434–460

    Google Scholar 

  158. Wood RE, Boat TF, Doershuk CF (1976) Cystic fibrosis. State of the Art. Am Rev Respir Dis 113:833–878

    Google Scholar 

  159. Wood RE, Leigh MW (1987) What is a “pulmonary exacerbation” in cystic fibrosis? J Pediatr 111:841

    Google Scholar 

  160. Wood RE, Wanner A, Hirsch J, Farrell PM (1975) Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis 111:733–738

    Google Scholar 

  161. Yamaguchi T, Yamada H (1991) Role of mechanical injury on airway surface in the pathogenesis of Pseudomonas aeruginosa. Am Rev Respir Dis 144:1147

    Google Scholar 

  162. Yassa JG, Prosser R, Dodge JA (1978) Effects of an artificial diet on growth of patients with cystic fibrosis. Arch Dis Child 53:777–783

    Google Scholar 

  163. Zach MS, Oberwaldner B, Forche G, Polgar G (1985) Bronchodilators increase airway instability in cystic fibrosis. Am Rev Respir Dis 131:537–543

    Google Scholar 

  164. Zach M, Oberwaldner B, Hausler F (1982) Cystic fibrosis: Physical exercise vs. chest physiotherapy. Arch Dis Child 57:587–589

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA

    M. R. Bye & J. M. Ewig

  2. Columbia University/Babies Hospital, New York, New York, USA

    L. M. Quittell

Authors
  1. M. R. Bye
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. J. M. Ewig
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. L. M. Quittell
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bye, M.R., Ewig, J.M. & Quittell, L.M. Cystic fibrosis. Lung 172, 251–270 (1994). https://doi.org/10.1007/BF00164308

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00164308

Key words